Trials / Completed
CompletedNCT03208101
A Study to Compare LBVD to Eupenta and Imovax Polio in Healthy Adults
A Single-center, Randomized, Active-controlled, Parallel-group, Open-label, Phase I Study to Evaluate Safety and Immunogenicity of Single Injection of LBVD or Eupenta Co-administered With Imovax Polio in Healthy Adults
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 42 (actual)
- Sponsor
- LG Chem · Industry
- Sex
- All
- Age
- 19 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
This is a single-center, randomized, active-controlled, parallel-group, open-label, phase I study to evaluate safety and immunogenicity of single injection of LBVD or Eupenta co-administered with Imovax Polio in healthy adults.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | DTP-HepB-IPV-Hib vaccine | Hexavalent vaccine (DTP-HepB-IPV-Hib vaccine: Diphtheria-Tetanus-Pertussis-Hepatitis B-Inactivated Poliovirus-Haemophilus influenzae type b vaccine) |
| BIOLOGICAL | DTP-HepB-Hib vaccine & IPV | Pentavalent vaccine (DTP-HepB-Hib vaccine: Diphtheria-Tetanus-Pertussis-Hepatitis B-Haemophilus influenzae type b vaccine)+ IPV(Inactivated poliovirus vaccine) |
Timeline
- Start date
- 2017-07-03
- Primary completion
- 2017-09-06
- Completion
- 2017-12-21
- First posted
- 2017-07-05
- Last updated
- 2019-08-29
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT03208101. Inclusion in this directory is not an endorsement.